These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 23410027)

  • 1. The histone deacetylase inhibitor, MS-275 (entinostat), downregulates c-FLIP, sensitizes osteosarcoma cells to FasL, and induces the regression of osteosarcoma lung metastases.
    Rao-Bindal K; Koshkina NV; Stewart J; Kleinerman ES
    Curr Cancer Drug Targets; 2013 May; 13(4):411-22. PubMed ID: 23410027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MS-275 sensitizes osteosarcoma cells to Fas ligand-induced cell death by increasing the localization of Fas in membrane lipid rafts.
    Rao-Bindal K; Zhou Z; Kleinerman ES
    Cell Death Dis; 2012 Aug; 3(8):e369. PubMed ID: 22875006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Fas/FasL Signaling Pathway: Its Role in the Metastatic Process and as a Target for Treating Osteosarcoma Lung Metastases.
    Koshkina N; Yang Y; Kleinerman ES
    Adv Exp Med Biol; 2020; 1258():177-187. PubMed ID: 32767242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Participation of the Fas/FasL signaling pathway and the lung microenvironment in the development of osteosarcoma lung metastases.
    Huang G; Nishimoto K; Yang Y; Kleinerman ES
    Adv Exp Med Biol; 2014; 804():203-17. PubMed ID: 24924176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of the histone deacetylase inhibitor SNDX-275 on Fas signaling in osteosarcoma cells and the feasibility of its topical application for the treatment of osteosarcoma lung metastases.
    Koshkina NV; Rao-Bindal K; Kleinerman ES
    Cancer; 2011 Aug; 117(15):3457-67. PubMed ID: 21287529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of c-FLIP in pulmonary metastases in osteosarcoma patients and human xenografts.
    Rao-Bindal K; Rao CK; Yu L; Kleinerman ES
    Pediatr Blood Cancer; 2013 Apr; 60(4):575-9. PubMed ID: 23255321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BIN1 tumor suppressor regulates Fas/Fas ligand-mediated apoptosis through c-FLIP in cutaneous T-cell lymphoma.
    Esmailzadeh S; Huang Y; Su MW; Zhou Y; Jiang X
    Leukemia; 2015 Jun; 29(6):1402-13. PubMed ID: 25578476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrine induces caspase-dependent apoptosis in human osteosarcoma cells in vitro and in vivo through the upregulation of Bax and Fas/FasL and downregulation of Bcl-2.
    Liang CZ; Zhang JK; Shi Z; Liu B; Shen CQ; Tao HM
    Cancer Chemother Pharmacol; 2012 Feb; 69(2):317-31. PubMed ID: 21717192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Histone Deacetylase Inhibitor Entinostat/Syndax 275 in Osteosarcoma.
    Kiany S; Harrison D; Gordon N
    Adv Exp Med Biol; 2020; 1257():75-83. PubMed ID: 32483732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aerosol therapy for the treatment of osteosarcoma lung metastases: targeting the Fas/FasL pathway and rationale for the use of gemcitabine.
    Gordon N; Kleinerman ES
    J Aerosol Med Pulm Drug Deliv; 2010 Aug; 23(4):189-96. PubMed ID: 20528149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of c-FLIP by RNAi enhances sensitivity of the human osteogenic sarcoma cell line U2OS to TRAIL-induced apoptosis.
    Zhang YP; Kong QH; Huang Y; Wang GL; Chang KJ
    Asian Pac J Cancer Prev; 2015; 16(6):2251-6. PubMed ID: 25824746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of Fas/FasL in the metastatic potential of osteosarcoma and targeting this pathway for the treatment of osteosarcoma lung metastases.
    Gordon N; Kleinerman ES
    Cancer Treat Res; 2009; 152():497-508. PubMed ID: 20213411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-20a encoded by the miR-17-92 cluster increases the metastatic potential of osteosarcoma cells by regulating Fas expression.
    Huang G; Nishimoto K; Zhou Z; Hughes D; Kleinerman ES
    Cancer Res; 2012 Feb; 72(4):908-16. PubMed ID: 22186140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corruption of the Fas pathway delays the pulmonary clearance of murine osteosarcoma cells, enhances their metastatic potential, and reduces the effect of aerosol gemcitabine.
    Gordon N; Koshkina NV; Jia SF; Khanna C; Mendoza A; Worth LL; Kleinerman ES
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4503-10. PubMed ID: 17671136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fas-negative osteosarcoma tumor cells are selected during metastasis to the lungs: the role of the Fas pathway in the metastatic process of osteosarcoma.
    Koshkina NV; Khanna C; Mendoza A; Guan H; DeLauter L; Kleinerman ES
    Mol Cancer Res; 2007 Oct; 5(10):991-9. PubMed ID: 17951400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cisplatin (CDDP) sensitizes human osteosarcoma cell to Fas/CD95-mediated apoptosis by down-regulating FLIP-L expression.
    Kinoshita H; Yoshikawa H; Shiiki K; Hamada Y; Nakajima Y; Tasaka K
    Int J Cancer; 2000 Dec; 88(6):986-91. PubMed ID: 11093825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FR901228 induces tumor regression associated with induction of Fas ligand and activation of Fas signaling in human osteosarcoma cells.
    Imai T; Adachi S; Nishijo K; Ohgushi M; Okada M; Yasumi T; Watanabe K; Nishikomori R; Nakayama T; Yonehara S; Toguchida J; Nakahata T
    Oncogene; 2003 Dec; 22(58):9231-42. PubMed ID: 14647441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VEGF165 is necessary to the metastatic potential of Fas(-) osteosarcoma cells but will not rescue the Fas(+) cells.
    Jia SF; Guan H; Duan X; Kleinerman ES
    J Exp Ther Oncol; 2008; 7(2):89-97. PubMed ID: 18771083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of c-FLIP sensitizes DU145 prostate cancer cells to Fas-mediated apoptosis.
    Hyer ML; Sudarshan S; Kim Y; Reed JC; Dong JY; Schwartz DA; Norris JS
    Cancer Biol Ther; 2002; 1(4):401-6. PubMed ID: 12432255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. c-Myc promotes tubular cell apoptosis in ischemia-reperfusion-induced renal injury by negatively regulating c-FLIP and enhancing FasL/Fas-mediated apoptosis pathway.
    Xu D; Wang B; Chen PP; Wang YZ; Miao NJ; Yin F; Cheng Q; Zhou ZL; Xie HY; Zhou L; Liu J; Wang XX; Xue H; Zhang W; Lu LM
    Acta Pharmacol Sin; 2019 Aug; 40(8):1058-1066. PubMed ID: 30593588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.